According to a recent LinkedIn post from Bright Uro, Vandalia Health has adopted the company’s Glean Urodynamics System, becoming the first reported user of the technology in West Virginia. The post credits Dr. Jaschar Shakuri-Rad and other urology leaders at Vandalia Health for championing the implementation and emphasizes their patient-focused clinical team.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights claims that Glean may remove several limitations of traditional catheter-based urodynamics testing, potentially enabling more natural data collection and individualized treatment planning. If broadly validated and adopted, such functionality could strengthen Bright Uro’s value proposition in urology diagnostics and support future revenue growth.
As described in the post, the collaboration with Vandalia Health suggests early traction for Glean in clinical settings and may serve as a reference site for further deployments. For investors, this development could indicate progress in commercial adoption, particularly if similar health systems follow suit and if improved patient experience drives wider demand over time.